United Therapeutics up in last quarter

United Therapeutics Corp., of Silver Spring, a biotechnology company that develops products to address chronic and life-threatening conditions, reported increases in profit and revenue for the quarter ended June 30. Net income was $111.9 million, or $2.35 per share, compared with $79.9 million and $1.60 for the same quarter in 2013. Revenue totaled $322.8 million, ...

Leave a Reply

Your email address will not be published. Required fields are marked *